RE: Start of a great November!29 Oct 2023 22:15
"Who will get the majority of the lab work for the new company? Inaphaea BioLabs."
No - from their website: "Inaphaea provides pharma partners with customised immuno and cancer cell-based assays for early drug discovery research and pre-clinical development."
VAL201 is going to be going into Clinical Trials, which Inaphaea does not cater for. Try and keep your ramping rooted in facts.